Centricity Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Centricity Wealth Management's DGX Position: Q1 2025 in Review
Centricity Wealth Management sold out of Quest Diagnostics (DGX) in Q1 2025, closing a stake of 28 shares — an estimated $4.22K sold.
Centricity Wealth Management first reported a position in DGX in Q4 2024 and held it in 1 quarter. The position peaked at $4.22K in Q4 2024. 968 funds tracked by Wall St. Rank hold DGX as of Q1 2025.
- Centricity Wealth Management reported no remaining Quest Diagnostics position as of Q1 2025 after selling out during the quarter.
- Centricity Wealth Management sold 28 Quest Diagnostics shares in Q1 2025, an estimated $4.22K.
- Centricity Wealth Management first reported a position in Quest Diagnostics in Q4 2024 and held it in 1 quarter.
- Centricity Wealth Management's Quest Diagnostics position peaked at $4.22K in Q4 2024.
- 968 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2025.
Based on Centricity Wealth Management's 13F filing for Q1 2025, filed 14 Apr 2025.